Advertisement
CNO vs MET
Which Stock Would AI Choose? CNO Financial Group (CNO) vs. MetLife (MET) Stock Comparison
Key Takeaways
- CNO delivered a strong Q2 2026 earnings beat and raised full-year operating EPS guidance by 8% at the midpoint, reflecting robust insurance product margins and sales momentum.
- MET reported solid Q1 2026 results with EPS outperformance and has continued its history of dividend growth, with Q2 2026 results scheduled for early August.
- CNO has shown stronger recent price appreciation, with YTD returns exceeding 30% and a smaller market capitalization compared to the larger, more diversified MET.
- Both companies operate in the life insurance sector, but MET benefits from greater scale, international exposure, and higher analyst price targets relative to its current valuation.
- Market sentiment has favored CNO’s recent catalysts, while MET maintains steady capital return programs including buybacks and dividend hikes.
Introduction
This comparison examines CNO Financial Group and MET in the life insurance and benefits sector. Both companies provide protection, retirement, and employee benefit products, yet they differ in scale, geographic reach, and recent performance trajectories. The analysis focuses on observable factors such as earnings trends, capital management, and relative price behavior to assist investors evaluating exposure to U.S. insurance names amid evolving interest rate and equity market conditions.
CNO Overview and Recent Performance
CNO Financial Group, Inc. focuses on middle-income American households through worksite, direct, and broker distribution channels for life, health, and annuity products. In recent market activity, the company reported second-quarter 2026 results that exceeded consensus estimates, with operating earnings per share significantly above analyst projections. Management raised full-year 2026 operating EPS guidance, citing sustained sales growth, favorable investment results, and disciplined expense management. The stock has posted substantial year-to-date gains, outperforming broader market benchmarks over multiple timeframes and trading near recent highs amid positive sentiment following the earnings release.
MET Overview and Recent Performance
MET is a global provider of life insurance, annuities, and employee benefits with significant operations in the United States, Asia, and Europe. The company delivered a first-quarter 2026 earnings beat driven by favorable underwriting and investment income. In recent weeks, MET announced another quarterly dividend increase and continues to execute share repurchases. Second-quarter 2026 results are scheduled for release in early August. The stock has recorded solid longer-term returns supported by consistent capital return policies and exposure to equity market gains, though near-term price action has been more measured ahead of the upcoming earnings report.
Trending AI Robots
Tickeron’s Trending AI Robots page highlights a curated selection of AI-powered trading bots optimized for prevailing market conditions. Tickeron offers hundreds of AI trading bots that execute strategies across thousands of tickers, employing varied approaches including momentum, mean-reversion, and breakout tactics over multiple timeframes. Only those demonstrating the strongest risk-adjusted performance metrics and alignment with current volatility and sector trends are featured in the trending section. Performance statistics, win rates, and drawdown profiles differ substantially among available bots, allowing users to review detailed backtests and live results before deployment. Review the latest selections on the Trending AI Robots page for additional context on automated strategies covering these and other securities.
Head-to-Head Comparison
CNO operates with a more concentrated U.S. focus and smaller market capitalization, offering higher sensitivity to domestic economic trends and worksite sales cycles. In contrast, MET provides broader diversification through international operations and employee benefits, contributing to greater earnings stability across cycles. Recent momentum has favored CNO following its guidance upgrade, while MET emphasizes predictable capital returns via dividends and buybacks. Risk considerations include CNO’s narrower product mix versus MET’s larger balance sheet and regulatory exposures. Sector sentiment remains constructive for both, supported by equity market strength and steady demand for protection products, though valuation multiples and analyst target dispersion reflect differences in scale and growth visibility.
Tickeron AI Verdict
Based on observable factors including recent earnings consistency, guidance momentum, and relative price stability, Tickeron’s AI models currently assign a modestly higher probability of favorable near-term positioning to CNO. The company’s post-earnings reaction and raised outlook provide clearer near-term catalysts compared with MET’s upcoming report. This assessment remains probabilistic and subject to new data releases.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNO is a Hold and MET is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNO’s FA Score shows that 2 FA rating(s) are green whileMET’s FA Score has 3 green FA rating(s).
- CNO’s FA Score: 2 green, 3 red.
- MET’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNO’s TA Score shows that 3 TA indicator(s) are bullish while MET’s TA Score has 3 bullish TA indicator(s).
- CNO’s TA Score: 3 bullish, 5 bearish.
- MET’s TA Score: 3 bullish, 5 bearish.
Price Growth
CNO (@Life/Health Insurance) experienced а -2.51% price change this week, while MET (@Life/Health Insurance) price change was +0.42% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was -3.49%. For the same industry, the average monthly price growth was -2.88%, and the average quarterly price growth was +4.17%.
Reported Earning Dates
CNO is expected to report earnings on Nov 04, 2026.
MET is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Life/Health Insurance (-3.49% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
| CNO | MET | CNO / MET | |
| Capitalization | 5.08B | 61.9B | 8% |
| EBITDA | N/A | N/A | - |
| Gain YTD | 28.814 | 25.038 | 115% |
| P/E Ratio | 18.91 | 18.67 | 101% |
| Revenue | 4.51B | 76B | 6% |
| Total Cash | N/A | N/A | - |
| Total Debt | 4.3B | 21.1B | 20% |
CNO | MET | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 83 | 81 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 52 Fair valued | 37 Fair valued | |
PROFIT vs RISK RATING 1..100 | 5 | 24 | |
SMR RATING 1..100 | 88 | 96 | |
PRICE GROWTH RATING 1..100 | 41 | 15 | |
P/E GROWTH RATING 1..100 | 20 | 18 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MET's Valuation (37) in the Life Or Health Insurance industry is in the same range as CNO (52). This means that MET’s stock grew similarly to CNO’s over the last 12 months.
CNO's Profit vs Risk Rating (5) in the Life Or Health Insurance industry is in the same range as MET (24). This means that CNO’s stock grew similarly to MET’s over the last 12 months.
CNO's SMR Rating (88) in the Life Or Health Insurance industry is in the same range as MET (96). This means that CNO’s stock grew similarly to MET’s over the last 12 months.
MET's Price Growth Rating (15) in the Life Or Health Insurance industry is in the same range as CNO (41). This means that MET’s stock grew similarly to CNO’s over the last 12 months.
MET's P/E Growth Rating (18) in the Life Or Health Insurance industry is in the same range as CNO (20). This means that MET’s stock grew similarly to CNO’s over the last 12 months.
| CNO | MET | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 57% | 2 days ago 61% |
| Stochastic ODDS (%) | 2 days ago 52% | 2 days ago 57% |
| Momentum ODDS (%) | 2 days ago 67% | 2 days ago 57% |
| MACD ODDS (%) | 2 days ago 49% | 2 days ago 60% |
| TrendWeek ODDS (%) | 2 days ago 48% | 2 days ago 59% |
| TrendMonth ODDS (%) | 2 days ago 61% | 2 days ago 53% |
| Advances ODDS (%) | 9 days ago 63% | 9 days ago 64% |
| Declines ODDS (%) | 2 days ago 48% | 2 days ago 52% |
| BollingerBands ODDS (%) | 2 days ago 58% | 2 days ago 58% |
| Aroon ODDS (%) | 2 days ago 61% | 2 days ago 53% |
Advertisement
CNO and
Correlation & Price change
A.I.dvisor indicates that over the last year, CNO has been loosely correlated with JXN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if CNO jumps, then JXN could also see price increases.
MET and
Correlation & Price change
A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.